EVFM · Evofem Biosciences
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a hormone-free contraceptive vaginal gel; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Market Cap
927.7K
52 Wk Range
$0.00 - $0.02
Previous Close
$0.01
Open
$0.01
Volume
5,570
Day Range
$0.01 - $0.01
Enterprise Value
51.99M
Cash
N/A
Avg Qtr Burn
-3.14M
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
Jun 30th 2026
